Nalaganje...
Risk-adapted therapy for young children with medulloblastoma (SJYC07): results and molecular analysis from a multicenter phase II trial
BACKGROUND: Young children with medulloblastoma have inferior survival to older children. While the principal difference is due to radiation-sparing therapy, radiation is not an absolute requisite for survival of all. We aimed to estimate the event-free survival of young medulloblastoma patients wit...
Shranjeno v:
| izdano v: | Lancet Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6078206/ https://ncbi.nlm.nih.gov/pubmed/29778738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(18)30204-3 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|